Cargando…
Let’s Focus on the Fibrosis in Dupuytren Disease: Cell Communication Network Factor 2 as a Novel Target
Dupuytren disease is a progressive, benign fibroproliferative disorder of the hands that can lead to debilitating hand contractures. Once symptomatic, treatment involves either surgical intervention, specifically fasciectomy or percutaneous needle aponeurotomy, or enzymatic degradation with clostrid...
Autores principales: | Lambi, Alex G., Morrell, Nathan T., Popoff, Steven N., Benhaim, Prosper, Barbe, Mary F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543811/ https://www.ncbi.nlm.nih.gov/pubmed/37790821 http://dx.doi.org/10.1016/j.jhsg.2023.06.017 |
Ejemplares similares
-
Blocking CCN2 Reduces Established Palmar Neuromuscular Fibrosis and Improves Function Following Repetitive Overuse Injury
por: Lambi, Alex G., et al.
Publicado: (2023) -
Development of Normal and Cleft Palate: A Central Role for Connective Tissue Growth Factor (CTGF)/CCN2
por: Tarr, Joseph T., et al.
Publicado: (2018) -
D3. Time from Collagenase Injection to Manipulation Does Not Affect Outcomes in Dupuytren’s Disease
por: Bingham, Elijah G., et al.
Publicado: (2023) -
Blocking CCN2 Reduces Established Bone Loss Induced by Prolonged Intense Loading by Increasing Osteoblast Activity in Rats
por: Lambi, Alex G, et al.
Publicado: (2023) -
Increased Serum and Musculotendinous Fibrogenic Proteins following Persistent Low-Grade Inflammation in a Rat Model of Long-Term Upper Extremity Overuse
por: Gao, Helen G. L., et al.
Publicado: (2013)